These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 35507071)

  • 1. Do psychedelics change beliefs?
    McGovern HT; Leptourgos P; Hutchinson BT; Corlett PR
    Psychopharmacology (Berl); 2022 Jun; 239(6):1809-1821. PubMed ID: 35507071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How do psychedelics work?
    Carhart-Harris RL
    Curr Opin Psychiatry; 2019 Jan; 32(1):16-21. PubMed ID: 30394903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What can neuroscience tell us about the potential of psychedelics in healthcare? How the neurophenomenology of psychedelics research could help us to flourish throughout our lives, as well as to enhance our dying.
    Mackenzie R
    Curr Drug Abuse Rev; 2014; 7(3):136-45. PubMed ID: 25563449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review.
    van Elk M; Yaden DB
    Neurosci Biobehav Rev; 2022 Sep; 140():104793. PubMed ID: 35878791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychedelics as Tools for Belief Transmission. Set, Setting, Suggestibility, and Persuasion in the Ritual Use of Hallucinogens.
    Dupuis D
    Front Psychol; 2021; 12():730031. PubMed ID: 34887799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychedelics and Neural Plasticity: Therapeutic Implications.
    Grieco SF; Castrén E; Knudsen GM; Kwan AC; Olson DE; Zuo Y; Holmes TC; Xu X
    J Neurosci; 2022 Nov; 42(45):8439-8449. PubMed ID: 36351821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.
    Vollenweider FX; Kometer M
    Nat Rev Neurosci; 2010 Sep; 11(9):642-51. PubMed ID: 20717121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.
    Moreton SG; Szalla L; Menzies RE; Arena AF
    Psychopharmacology (Berl); 2020 Jan; 237(1):21-32. PubMed ID: 31784805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethical Issues Regarding Nonsubjective Psychedelics as Standard of Care.
    Yaden DB; Earp BD; Griffiths RR
    Camb Q Healthc Ethics; 2022 Oct; 31(4):464-471. PubMed ID: 36398520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications.
    Kraehenmann R
    Curr Neuropharmacol; 2017; 15(7):1032-1042. PubMed ID: 28625125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-blinding citizen science to explore psychedelic microdosing.
    Szigeti B; Kartner L; Blemings A; Rosas F; Feilding A; Nutt DJ; Carhart-Harris RL; Erritzoe D
    Elife; 2021 Mar; 10():. PubMed ID: 33648632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis.
    Dourron HM; Strauss C; Hendricks PS
    Pharmacol Rev; 2022 Oct; 74(4):982-1027. PubMed ID: 36113878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modalities of the psychedelic experience: Microclimates of set and setting in hallucinogen research and culture.
    Hartogsohn I
    Transcult Psychiatry; 2022 Oct; 59(5):579-591. PubMed ID: 35818775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An introduction to psychedelic neuroscience.
    Calvey T; Howells FM
    Prog Brain Res; 2018; 242():1-23. PubMed ID: 30471677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human behavioral pharmacology of psychedelics.
    Strickland JC; Johnson MW
    Adv Pharmacol; 2022; 93():105-132. PubMed ID: 35341564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The History of Psychedelics in Psychiatry.
    Nichols DE; Walter H
    Pharmacopsychiatry; 2021 Jul; 54(4):151-166. PubMed ID: 33285579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classic Psychedelic Drugs: Update on Biological Mechanisms.
    Vollenweider FX; Smallridge JW
    Pharmacopsychiatry; 2022 May; 55(3):121-138. PubMed ID: 35079988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics.
    Tófoli LF; de Araujo DB
    Int Rev Neurobiol; 2016; 129():157-85. PubMed ID: 27503452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular targets of psychedelic-induced plasticity.
    Jaster AM; de la Fuente Revenga M; González-Maeso J
    J Neurochem; 2022 Jul; 162(1):80-88. PubMed ID: 34741320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.
    Johnson MW; Hendricks PS; Barrett FS; Griffiths RR
    Pharmacol Ther; 2019 May; 197():83-102. PubMed ID: 30521880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.